Filing Details

Accession Number:
0001209191-19-031450
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-20 17:08:20
Reporting Period:
2019-05-16
Accepted Time:
2019-05-20 17:08:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1697532 Applied Therapeutics Inc. APLT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216955 S Joel Marcus C/o Applied Therapeutics, Inc.
340 Madison Avenue, 19Th Floor
New York NY 10173
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-16 110,497 $0.00 119,668 No 4 C Direct
Common Stock Acquisiton 2019-05-16 135,192 $0.00 254,860 No 4 C Direct
Common Stock Acquisiton 2019-05-16 150,000 $10.00 404,860 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-05-16 110,497 $0.00 110,497 $0.00
Common Stock Series B Preferred Stock Disposition 2019-05-16 135,192 $0.00 135,192 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019.